US equity research is sharply split by time horizon right now, with no clean consensus for the broader market.
Near-term, one camp of analysts flags momentum divergences, weakening technicals, and rising yields as headwinds for the S&P 500 and Russell 2000. A contrarian thread of recently-published research pushes further, arguing stretched valuations and overblown AI profit expectations leave US equities vulnerable over the coming months — hence a "short US, long UK" trade highlighted in a widely-cited fund manager survey.
On the other side, researchers point to a still-accelerating AI investment cycle — strong earnings, upgraded capex plans, robust cloud demand — as the engine keeping equities bid. Some constructive views argue market breadth is widening beyond mega caps into small caps and sector adopters of AI, with Industrials and Healthcare flagged as beneficiaries.
One staged thesis worth noting: bullish on US large-cap tech through mid-to-late 2027 as AI capex runs, then bearish into 2028 as growth saturates.